Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2

Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix I and Appendix II ). Updates are published regularly and can be found on the ASCO Publications website .

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-06-29
DOI
https://doi.org/10.1200/jco-26-01479
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2

Yubao Wang, Natasha B. Leighl, Janet Freeman‐Daily, Logan Roof et al.
Journal of Clinical Oncology
Lung Cancer Diagnosis and Treatment
article

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2

Yubao Wang, Natasha B. Leighl, Janet Freeman‐Daily, Logan Roof, Paul Wheatley‐Price, M. Sara Kuruvilla, Sonam Puri, Naoki Furuya, Nofisat Ismaila, Ibrahim Azar, Ana I. Velázquez
article en

Abstract

Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix I and Appendix II ). Updates are published regularly and can be found on the ASCO Publications website .

Journal of Clinical Oncology
Lovelace Respiratory Research Institute (US), American Society of Clinical Oncology (US), University Health Network (CA), University of Ottawa (CA), St. Marianna University School of Medicine (JP), University of California, San Francisco (US), Ottawa Hospital (CA), London Health Sciences Centre (CA), Princess Margaret Cancer Centre (CA), Moffitt Cancer Center (US), Lovelace Medical Center (US), Rosetta Stone (United States) (US), IHA Hematology Oncology Consultants (US), The Ohio State University (US)
Openalex Percentile: Top 8%
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.